Tuberculosis and Respiratory Diseases

Search

Page Path

Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey: Yong Bum Park, Jin Hwa Lee, Seung Won Ra, Hye Yun Park, Ji Ye Jung, Young Ae Kang, Chin Kook Rhee, Deog Kyeom Kim, Kwang Ha Yoo, Yong Il Hwang, Seong Yong Lim, Jae Seung Lee, Kyung-Wook Jo, Yeon-Mok Oh; Tuberc Respir Dis. 2023;86(3):196-202. Published online May 31, 2023; DOI: https://doi.org/10.4046/trd.2023.0014
Web of Science 2 Crossref 2; Full text PubReader ePub PDF

The Importance of Early Chronic Obstructive Pulmonary Disease: A Lecture from 2022 Asian Pacific Society of Respirology: Don D. Sin; Tuberc Respir Dis. 2023;86(2):71-81. Published online March 28, 2023; DOI: https://doi.org/10.4046/trd.2023.0005
Web of Science 11 Crossref 12; Full text PubReader ePub PDF

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184

MOST VIEWED MOST CITED

21,142	Clonal Hematopoiesis of Indeterminate Potential Is Associated with Current Smoking Status and History of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease
7,803	Effects of the Use of Beta-Blockers on Chronic Obstructive Pulmonary Disease Associated with Cardiovascular Comorbities: Systematic Review and Meta-analysis
3,602	Regenerative Capacity of Alveolar Type 2 Cells Is Proportionally Reduced Following Disease Progression in Idiopathic Pulmonary Fibrosis-Derived Organoid Cultures
2,682	Disease Severity and Activity in Bronchiectasis: A Paradigm Shift in Bronchiectasis Management
3,410	Tuberculosis Notification and Incidence: Republic of Korea, 2022

Cited By 25	Tuberculosis: Republic of Korea, 2021
Cited By 13	Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model
Cited By 12	The Importance of Early Chronic Obstructive Pulmonary Disease: A Lecture from 2022 Asian Pacific Society of Respirology
Cited By 6	New Targeted Therapy for Non-Small Cell Lung Cancer
Cited By 6	Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse

Editorial Office: 101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347 Fax: +82-2-572-6683 E-mail: katrdsubmit@lungkorea.org